Related Experiment Video
Updated: Feb 19, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate
Frank Theil1, Johanna Milsmann1, Samuel O Kyeremateng1
1AbbVie Deutschland GmbH & Co. KG , 67061 Ludwigshafen, Germany.
Kinetically stabilized amorphous solid dispersions (ASDs) containing fenofibrate remained amorphous for 15 years, demonstrating long-term physical stability. This challenges the notion that ASDs are inherently prone to recrystallization, highlighting kinetic stabilization
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Physical Chemistry
Background:
- Amorphous solid dispersions (ASDs) are crucial for enhancing drug bioavailability but face challenges with recrystallization.
- The long-term physical stability of ASDs, particularly their resistance to crystallization, remains a critical area of investigation.
- Recrystallization can compromise drug efficacy by reducing bioavailability and potentially lowering the effective dose.
Purpose of the Study:
- To investigate the long-term physical stability of a kinetically stabilized amorphous solid dispersion (ASD) of fenofibrate.
- To assess the potential for recrystallization in ASD formulations over an extended storage period (15 years).
- To evaluate the efficacy of kinetic stabilization in preventing drug crystallization in ASDs.
Main Methods:
- Physicochemical characterization of a 15-year-old fenofibrate ASD formulation compared to a fresh batch.
- Assessment of crystallinity using polarized light microscopy (PLM) and X-ray powder diffraction (XRPD).
- Investigation of crystal growth kinetics via transmission Raman spectroscopy (TRS) to develop a predictive model.
Main Results:
- The 15-year-old fenofibrate ASD formulation remained physically stable and amorphous.
- Comprehensive characterization confirmed content, purity, water content, and glass transition properties were maintained.
- The developed predictive model successfully forecasted the amorphous state of the aged ASD samples.
Conclusions:
- Kinetic stabilization alone is sufficient to prevent crystallization in ASDs over prolonged storage periods (at least 15 years).
- This study demonstrates the potential for long-term physical stability in certain ASD formulations.
- The findings suggest a need to re-evaluate the perceived risk of recrystallization in kinetically stabilized ASDs.
Related Concept Videos
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drug Product Stability
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Factors Influencing Drug Absorption: Pharmaceutical Parameters

